CYCC beat EPS expectations by 53.10%
May 14, 2024, 11:33 PM
0.00%
Cyclacel Pharmaceuticals Inc (CYCC) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Cyclacel Pharmaceuticals Inc's actual EPS was -$2.27, beating the estimate of -$4.84 per share, resulting in a 53.10% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.